{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:51:58Z","timestamp":1790985118665,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2010012"],"award-info":[{"award-number":["W81XWH2010012"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA230610"],"award-info":[{"award-number":["R01CA230610"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA289581"],"award-info":[{"award-number":["R01CA289581"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA076292"],"award-info":[{"award-number":["P30-CA076292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015013","name":"State of Florida Department of State","doi-asserted-by":"publisher","award":["25B12"],"award-info":[{"award-number":["25B12"]}],"id":[{"id":"10.13039\/100015013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xcrm.2026.102788","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:44:04Z","timestamp":1778078644000},"page":"102788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretion"],"prefix":"10.1016","volume":"7","author":[{"given":"Alexis","family":"Onimus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana","family":"Celias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Mandula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alycia","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"H\u00e4nggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olabisi","family":"Osunmakinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy I.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-6872","authenticated-orcid":false,"given":"Brian","family":"Ruffell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102788_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081823","article-title":"Necroptosis in Immuno-Oncology and Cancer Immunotherapy","volume":"9","author":"Sprooten","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.102788_bib6","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.xcrm.2026.102788_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108130","article-title":"ATP and cancer immunosurveillance","volume":"40","author":"Kepp","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2026.102788_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.aad0779","article-title":"Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1","volume":"350","author":"Vacchelli","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.xcrm.2026.102788_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death","volume":"6","author":"Garg","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cdd.2013.72","article-title":"Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists","volume":"21","author":"Yamazaki","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.102788_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102788_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102788_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","article-title":"Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy","volume":"1","author":"DeNardo","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102788_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/2326-6066.CIR-14-0232","article-title":"TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy","volume":"3","author":"Shiao","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102788_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2017.11.019","article-title":"TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer","volume":"33","author":"de Mingo Pulido","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib17","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102788_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003571","article-title":"TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8(+) T cell and XCR1(+) dendritic cell spatial co-localization","volume":"10","author":"Gardner","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102788_bib19","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/bi2000214","article-title":"Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA","volume":"50","author":"Park","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.xcrm.2026.102788_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.23021","article-title":"Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia\/reperfusion injury","volume":"50","author":"Cardinal","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102788_bib21","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1039\/C4SC03650F","article-title":"HMGB1 bound to cisplatin-DNA adducts undergoes extensive acetylation and phosphorylation in vivo","volume":"6","author":"He","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1016\/j.xcrm.2026.102788_bib22","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1074\/jbc.M701465200","article-title":"Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus","volume":"282","author":"Ditsworth","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102788_bib23","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcp.25352","article-title":"Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages","volume":"231","author":"Chen","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.xcrm.2026.102788_bib24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.bbrc.2018.07.112","article-title":"KPT-330, a potent and selective CRM1 inhibitor, exhibits anti-inflammation effects and protection against sepsis","volume":"503","author":"Wu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2026.102788_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01189","article-title":"Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology","volume":"11","author":"Kwak","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","article-title":"The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway","volume":"3","author":"Gardella","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.xcrm.2026.102788_bib28","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion","volume":"22","author":"Bonaldi","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2026.102788_bib71","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1158\/0008-5472.CAN-14-0067","article-title":"Ran S.Paclitaxel therapy promotes breast cancer metastatsis in a TLR4-dependent manner","volume":"74","author":"Volk-Draper","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102788_bib74","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/09680519010070030701","article-title":"Involvement of TLR4\/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol","volume":"7","author":"Kawasaki","year":"2001","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.xcrm.2026.102788_bib75","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1521-4141(200108)31:8<2448::AID-IMMU2448>3.0.CO;2-N","article-title":"The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol","volume":"3","author":"Byrd-Leifer","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xcrm.2026.102788_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","article-title":"Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk","volume":"141","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2026.102788_bib72","article-title":"Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis","volume":"9","author":"Yang","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.xcrm.2026.102788_bib73","first-page":"3411","article-title":"TRL4\/MyD88 signaling determines the metastatic potential of breast cancer cells","volume":"18","author":"Wu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.xcrm.2026.102788_bib29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12672-025-02509-z","article-title":"The role of TLR-4 in chemoresistance of cancer","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.xcrm.2026.102788_bib35","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1002\/jcp.30166","article-title":"The role of toll-like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?","volume":"236","author":"Kashani","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.xcrm.2026.102788_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1189\/jlb.0806540","article-title":"Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1","volume":"81","author":"Tang","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102788_bib76","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/labinvest.2013.79","article-title":"Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells","volume":"93","author":"Pi","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.xcrm.2026.102788_bib77","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.173.6.3589","article-title":"Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kB","volume":"173","author":"Park","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib78","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/cdd.2010.26","article-title":"Heat shock protein gp96 and NAD(P)H oxidase 4 plays key roles in Toll-like receptor 4-activated apoptosis during renal ischemia\/reperfusion injury","volume":"17","author":"Ben Mkaddem","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.xcrm.2026.102788_bib79","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/srep00896","article-title":"Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia","volume":"2","author":"Suzuki","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102788_bib32","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.4049\/jimmunol.1400359","article-title":"PARP-1 mediates LPS-induced HMGB1 release by macrophages through regulation of HMGB1 acetylation","volume":"193","author":"Yang","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib80","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib81","doi-asserted-by":"crossref","first-page":"eabd4811","DOI":"10.1126\/scitranslmed.abd4811","article-title":"Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel","volume":"13","author":"Scribano","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib82","doi-asserted-by":"crossref","first-page":"229ra43","DOI":"10.1126\/scitranslmed.3007965","article-title":"Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles","volume":"6","author":"Zasadil","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ccell.2018.04.010","article-title":"Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells","volume":"33","author":"Canovas","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102788_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.137.1.93","article-title":"Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells","volume":"137","author":"Rodr\u00edguez","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102788_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0962-8924(00)01794-3","article-title":"Regulated secretion of conventional lysosomes","volume":"10","author":"Andrews","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102788_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(01)00421-4","article-title":"Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes","volume":"106","author":"Reddy","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102061","article-title":"Regulation of calcium homeostasis and flux between the endoplasmic reticulum and the cytosol","volume":"298","author":"Daverkausen-Fischer","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102788_bib41","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ccell.2024.10.014","article-title":"Interleukin-1 alpha release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity","volume":"42","author":"Hanggi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib42","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1158\/1078-0432.CCR-22-1110","article-title":"FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer","volume":"28","author":"Shah","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102788_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.102788_bib44","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102788_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102788_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00232-019-00104-2","article-title":"Transient Receptor Potential Ankyrin 1 Contributes to Lysophosphatidylcholine-Induced Intracellular Calcium Regulation and THP-1-Derived Macrophage Activation","volume":"253","author":"Tian","year":"2020","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.xcrm.2026.102788_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155769","article-title":"Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease","volume":"152","author":"Du","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.xcrm.2026.102788_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-cellbio-120219-035530","article-title":"Mechanisms of Selective Autophagy","volume":"37","author":"Lamark","year":"2021","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.102788_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/cdd.2008.143","article-title":"Autophagy regulates selective HMGB1 release in tumor cells that are destined to die","volume":"16","author":"Thorburn","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.102788_bib50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102788_bib51","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41418-018-0251-z","article-title":"STING directly activates autophagy to tune the innate immune response","volume":"26","author":"Liu","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.102788_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400038","article-title":"Omegasomes control formation, expansion, and closure of autophagosomes","volume":"46","author":"N\u00e4hse","year":"2024","journal-title":"Bioessays"},{"key":"10.1016\/j.xcrm.2026.102788_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217024","article-title":"Lysosomal exocytosis: From cell protection to protumoral functions","volume":"597","author":"Trojani","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2026.102788_bib54","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1080\/15548627.2020.1826690","article-title":"Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion","volume":"17","author":"Kim","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.xcrm.2026.102788_bib55","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-21-0195","article-title":"Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer","volume":"20","author":"Hu","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.xcrm.2026.102788_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41467-019-13689-y","article-title":"STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment","volume":"11","author":"Lohard","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102788_bib57","article-title":"STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation?","volume":"11","author":"Smith","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib58","article-title":"NF-kappaB activation enhances STING signaling by altering microtubule-mediated STING trafficking","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102788_bib59","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41556-021-00659-0","article-title":"The STING phase-separator suppresses innate immune signalling","volume":"23","author":"Yu","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102788_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012048","article-title":"Microtubule disruption synergizes with STING signaling to show potent and broad-spectrum antiviral activity","volume":"20","author":"Han","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102788_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235962","article-title":"The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models","volume":"14","author":"Takahashi-Ruiz","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102788_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57837","article-title":"Reactive oxygen species oxidize STING and suppress interferon production","volume":"9","author":"Tao","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.102788_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888147","article-title":"Post-Translational Modifications of STING: A Potential Therapeutic Target","volume":"13","author":"Kang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib65","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","article-title":"Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4\/IKK2\/SNARE-Dependent Exocytosis","volume":"8","author":"Lau","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102788_bib66","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41467-023-37217-1","article-title":"Epigenetic state determines the in vivo efficacy of STING agonist therapy","volume":"14","author":"Falahat","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102788_bib67","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ccell.2022.08.016","article-title":"Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses","volume":"40","author":"Mandula","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102788_bib70","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41467-018-03600-6","article-title":"Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance","volume":"9","author":"Meyer","year":"2018","journal-title":"Nat Commun."},{"key":"10.1016\/j.xcrm.2026.102788_bib68","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein HMGB1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102788_bib69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12859-023-05393-y","article-title":"PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing","volume":"24","author":"Obermayer","year":"2023","journal-title":"BMC Bioinf."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:36:59Z","timestamp":1783129019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666379126002053"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102788","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretion","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102788"}}